Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

3-Aminopyridine-2-carboxaldehyde Thiosemicarbazone in Treating Patients With Solid Tumors

This study has been completed.
Information provided by:
National Cancer Institute (NCI) Identifier:
First received: January 28, 2000
Last updated: July 17, 2013
Last verified: December 2007
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2008
  Estimated Primary Completion Date: No date given